Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Bianic · SciRah

Researcher profile · Semantic Scholar

F. Bianic

Share profile

F. Bianic — researcher profile on SciRah

h-index: 11
Works: 59
Citations: 423

Most-cited papers

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy
F. Mennini, P. Bonanni, F. Bianic, C. de Waure +5 more
2017Cost Effectiveness and Resource Allocation50 citations Open access
Semantic Scholar
Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis
J. Reginster, F. Bianic, R. Campbell, M. Martin +2 more
2017Osteoporosis International49 citations Open access
Semantic Scholar
Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers.
R. Nabbout, M. Dirani, T. Teng, F. Bianic +4 more
2020Epilepsy & Behavior45 citations Open access
Semantic Scholar
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany
N. Largeron, K. Petry, J. Jacob, F. Bianic +2 more
2017Expert review of pharmacoeconomics & outcomes research44 citations
Semantic Scholar
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients
S. Cure, F. Bianic, S. Gavart, S. Curtis +2 more
2014Journal of Medical Economics33 citations Open access
Semantic Scholar
Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients
S. Cure, F. Bianic, S. Gavart, S. Curtis +2 more
2014Journal of Medical Economics29 citations Open access
Semantic Scholar
Cost‐effectiveness of highly purified omega‐3 polyunsaturated fatty acid ethyl esters in the treatment of chronic heart failure: results of Markov modelling in a UK setting
M. Cowie, S. Cure, F. Bianic, A. Mcguire +2 more
2011European Journal of Heart Failure29 citations Open access
Semantic Scholar
Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis
S. Cure, J. Diels, S. Gavart, F. Bianic +1 more
2012Current Medical Research and Opinion20 citations Open access
Semantic Scholar
Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany
E. Préaud, M. Uhart, K. Böhm, P. Aidelsburger +3 more
2015Human Vaccines & Immunotherapeutics19 citations Open access
Semantic Scholar
The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older
J. López-Belmonte, R. Cisterna, Ángel Gil de Miguel, C. Guilmet +2 more
2016Journal of Medical Economics18 citations Open access
Semantic Scholar
Cost Utility of Telaprevir–PR (Peginterferon–Ribavirin) Versus Boceprevir–PR and Versus PR Alone in Chronic Hepatitis C in The Netherlands
Aikaterini Vellopoulou, M. van Agthoven, A. van der Kolk, R. de Knegt +4 more
2014Applied Health Economics and Health Policy13 citations Open access
Semantic Scholar
Estimating public health and economic benefits along 10 years of Fluzone® High Dose in the United States.
P. Net, F. Colrat, Mafalda Nascimento Costa, F. Bianic +2 more
2021Vaccine11 citations Open access
Semantic Scholar
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
J. Stahmeyer, S. Schauer, S. Rossol, Hans Heinrich Wedemeyer +3 more
2013Journal of health economics and outcomes research11 citations Open access
Semantic Scholar
Epidemiology of Distal Renal Tubular Acidosis: A Study Using Linked UK Primary Care and Hospital Data
F. Bianic, F. Guelfucci, Ludovic Robin, C. Martre +2 more
2021Nephron9 citations Open access
Semantic Scholar
Systematic Literature Review and Meta-Analysis of Renal Function in Human Immunodeficiency Virus (HIV)-Infected Patients Treated with Atazanavir (ATV)-Based Regimens
S. Cure, F. Bianic, C. Espinas, H. Hardy +2 more
2015PLoS ONE9 citations Open access
Semantic Scholar
Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting
F. Bianic, R. Campbell, V. Damera, P. de Simone +3 more
2016Journal of Medical Economics5 citations Open access
Semantic Scholar
An Economic Model To Estimate The Public Health Impact and Cost-Effectiveness of Vaccination of Seniors with Fluzone High Dose Influenza Vaccine in Australia
N. Largeron, A. Manton, P. Net, S. Choi +4 more
2018Value in Health4 citations Open access
Semantic Scholar
PIN30 - AN ECONOMIC MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF TRIVALENT INFLUENZA VACCINE HIGH DOSE FOR THE ELDERLY POPULATION IN ENGLAND AND WALES
J. Jacob, F. Bianic, L. Skinner, S. Carroll +4 more
2018Value in Health4 citations Open access
Semantic Scholar
Estimating The Cost-Effectiveness Profile Of A Vaccination Programme With A Nine-Valent Hpv Vaccine In Italy.
F. Mennini, F. Bianic, G. Baio, N. Largeron +4 more
2015Value in Health4 citations Open access
Semantic Scholar
RWD111 Influenza Vaccine Sales During the COVID-19 Era
A. Ngami, T. Christie, F. Guelfucci, F. Bianic +1 more
2022Value in Health3 citations Open access
Semantic Scholar
PIN20 EXPECTED COST-EFFECTIVENESS OF HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINES IN ENGLAND AND WALES: ASSESSMENTS USING DIRECT AND INDIRECT COMPARATIVE EFFECTIVENESS DATA
L. Skinner, A. Chit, F. Bianic, N. Largeron +2 more
2019Value in Health3 citations Open access
Semantic Scholar
Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)
P. Dandekar, J. Gregson, R. Campbell, F. Bianic
2015Pediatric Rheumatology Online Journal2 citations Open access
Semantic Scholar
POSB192 Public Health and Economic Impact of Influenza Immunization by Pharmacists: A Systematic Literature Review and Analysis of the French Experience
D. Proshenska, G. Menin, F. Bianic, P. Net
2022Value in Health1 citations Open access
Semantic Scholar
1005P Indirect treatment comparisons of relative efficacy for aumolertinib vs osimertinib in EGFR-positive non-small cell lung cancer (NSCLC)
S. Popat, S. Stergiopoulos, S. King, M. Curtis +9 more
2022Annals of Oncology1 citations Open access
Semantic Scholar
EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?
A. Ngami, T. Christie, F. Guelfucci, F. Bianic +1 more
2022Value in Health1 citations Open access
Semantic Scholar
a study using
F. Bianic, F. Guelfucci, Ludovic Robin, C. Martre +1 more
20211 citations
Semantic Scholar
PIN45 The Challenges of Estimating the Comprehensive Dengue Economic Burden
A. Petitjean, P. Net, F. Bianic
20201 citations Open access
Semantic Scholar
PUK18 DISTAL RENAL TUBULAR ACIDOSIS, A RARE RENAL CONDITION THAT IS OFTEN UNDIAGNOSED: UK STUDY USING CPRD DATABASE
F. Bianic, M. Martin, L. Robin, C. Martre +2 more
2019Value in Health1 citations Open access
Semantic Scholar
Estimating The Public Health Impact Of A Vaccination Programme With A Nonavalent Hpv Vaccine In Germany.
N. Largeron, K. Petry, J. Jacob, F. Bianic +2 more
2015Value in Health1 citations Open access
Semantic Scholar
PIN62 Cost-Effectiveness of Triple Therapy With Telaprevir for the Treatment of Treatment-Naïve Genotype 1 Chronic Hepatitis C Patients in Germany
J. Stahmeyer, S. Schauer, D. Wirth, J. Fleischmann +5 more
20121 citations Open access
Semantic Scholar
PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the Netherlands
K. Vellopoulou, M. van Agthoven, A. van der Kolk, M. Lamotte +2 more
20121 citations Open access
Semantic Scholar
9081 POSTER Network Meta-analysis of Second and Third-line Treatments on Overall Response and Overall Survival in Patients With Metastatic Non-small Cell Lung Cancer
F. Bianic, N. Despiégel, S. Cure, J. Campbell +3 more
20111 citations
Semantic Scholar
P33 Inflation Reduction Act Data Collection Provisions
C. Vossen, K. Mahony, F. Bianic, F. Guelfucci +1 more
2024Value in Health0 citations
Semantic Scholar
A population-adjusted indirect treatment comparison of efficacy and safety of aumolertinib vs osimertinib in EGFR-mutated non-small cell lung cancer
Sara King, Stella Stergiopoulos, Melissa D. Curtis, A. Dillon +10 more
2023Lung Cancer0 citations
Semantic Scholar
POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States
A. Ngami, T. Christie, G. Menin, F. Guelfucci +2 more
2022Value in Health0 citations Open access
Semantic Scholar
POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital
L. Cazin, A. Ngami, L. Parrenne, F. Lemercier +4 more
2022Value in Health0 citations Open access
Semantic Scholar
CO124 Indirect Comparison of Efficacy and Safety for Aumolertinib vs Osimertinib in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
S. Stergiopoulos, S. King, M. Curtis, S. Dillon +10 more
2022Value in Health0 citations Open access
Semantic Scholar
EE426 Budget Impact Analysis of Atezolizumab in 1ST Line Treatment for Patients With PD-L1 High Metastatic NSCLC From a French Payor Perspective
K. Benyounes, M. Delzard, K. Le Lay, F. Bianic +1 more
2022Value in Health0 citations Open access
Semantic Scholar
POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season
A. Ngami, F. Guelfucci, F. Bianic, P. Net
2022Value in Health0 citations Open access
Semantic Scholar
HPR202 Use of Real-World Data in Regulatory and Reimbursement Submissions for Personalized Medicines in Europe
C. Chagneau, F. Bianic, F. Guelfucci, C. Sysavath +1 more
2022Value in Health0 citations Open access
Semantic Scholar
POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies
P. Net, J. de Renteria, F. Bianic
2022Value in Health0 citations Open access
Semantic Scholar
HTA205 Time to Reimbursement Decisions for Personalized Medicines in the UK and France
C. Chagneau, F. Bianic, T. Isherwood, C. Vossen
2022Value in Health0 citations Open access
Semantic Scholar
Impact sur la santé publique de l’introduction en France d’un vaccin grippal quadrivalent inactivé haute dose (60 μg hémagglutinine/souche)
M. Costa, F. Bianic, F. P. Alvarez, M. Levant +1 more
2021Infectious Diseases Now0 citations
Semantic Scholar
PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population
M. Costa, P. Net, D. Proshenska, F. Bianic +1 more
2020Value in Health0 citations Open access
Semantic Scholar
PUK17 CYSTINURIA, A RARE RENAL CONDITION THAT IS OFTEN UNDIAGNOSED: UK STUDY USING CPRD DATABASE
F. Bianic, M. Martin, L. Robin, C. Martre +1 more
2019Value in Health0 citations Open access
Semantic Scholar
Estimating The Management Cost of HPV-Related Low-Grade and Precancerous High-Grade Lesions in France
M. Uhart, Jorge M. Jacob, J. Gagnon, F. Bianic +2 more
20160 citations Open access
Semantic Scholar
AB1129 Hyper Immunoglobulin D Syndrome (HIDS): Understanding What it is Like to Live with this Rare Condition
J. Gregson, F. Bianic, F. Bourhis
20150 citations
Semantic Scholar
Stima dell’impatto sulla salute pubblica di un programma di vaccinazione con il vaccino nonovalente anti HPV in Italia
P. Bonanni, F. Mennini, C. de Waure, G. Baio +4 more
20150 citations
Semantic Scholar
AB1131 Living with Tumour Necrosis Factor Receptor-Associated Periodic Fever Syndrome (TRAPS)
J. Gregson, F. Bianic, R. Campbell
20150 citations
Semantic Scholar
Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting.
F. Bianic, R. Campbell, Simone P. De, A. Roccia +1 more
2014Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Guelfucci×11
Invite
F. Guelfucci — researcher profile on SciRah
P. Net×10
Invite
P. Net — researcher profile on SciRah
N. Largeron×9
Invite
N. Largeron — researcher profile on SciRah
S. Cure×9
Invite
S. Cure — researcher profile on SciRah

×8

Invite

A. Ngami — researcher profile on SciRah

Invite

M. Uhart — researcher profile on SciRah

Invite

S. Gavart — researcher profile on SciRah

F. P. Alvarez×4

Invite

F. P. Alvarez — researcher profile on SciRah

Invite

C. Martre — researcher profile on SciRah

Invite

D. Game — researcher profile on SciRah

Invite

J. Gregson — researcher profile on SciRah

Invite

C. de Waure — researcher profile on SciRah